Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|
| Operating cash flow (Indirect Method) | |||
| Cash from operating activities | 97.15%2.35B | 54.86%1.19B | 771M |
| Net profit before non-cash adjustment | -26.07%1.46B | 1,077.98%1.98B | --168M |
| Total adjustment of non-cash items | 222.91%633M | -165.03%-515M | --792M |
| -Depreciation and amortization | 4.79%613M | 31.46%585M | --445M |
| -Reversal of impairment losses recognized in profit and loss | -29.00%213M | -15.73%300M | --356M |
| -Disposal profit | -128.97%-42M | 2,800.00%145M | --5M |
| -Other non-cash items | 90.23%-151M | -10,935.71%-1.55B | ---14M |
| Changes in working capital | 196.64%259M | -40.31%-268M | ---191M |
| -Change in receivables | 1,605.26%324M | -66.67%19M | --57M |
| -Change in inventory | -168.89%-31M | 127.44%45M | ---164M |
| -Change in payables | 288.68%100M | -32.50%-53M | ---40M |
| -Provision for loans, leases and other losses | 91.15%-33M | -3,008.33%-373M | ---12M |
| -Changes in other current assets | -207.45%-101M | 393.75%94M | ---32M |
| Dividends paid (cash flow from operating activities) | |||
| Dividends received (cash flow from operating activities) | |||
| Interest paid (cash flow from operating activities) | -14.86%-85M | -51.02%-74M | -49M |
| Interest received (cash flow from operating activities) | 75.00%7M | 300.00%4M | 1M |
| Tax refund paid | 14.47%-408M | -4.15%-477M | -458M |
| Other operating cash inflow (outflow) | -95.39%25M | 788.52%542M | 61M |
| Operating cash flow | 59.21%1.89B | 264.72%1.19B | --326M |
| Investing cash flow | |||
| Net business purchase and sale | 88.76%-96M | -191.47%-854M | ---293M |
| Net investment product transactions | -33.11%198M | 14,700.00%296M | --2M |
| Advance cash and loans provided to other parties | --0 | -97.50%-79M | ---40M |
| Dividends received (cash flow from investment activities) | 150.00%40M | --16M | ---- |
| Net changes in other investments | -283.95%-311M | 19.00%-81M | ---100M |
| Investing cash flow | 75.93%-169M | -62.88%-702M | ---431M |
| Financing cash flow | |||
| Net issuance payments of debt | -143.74%-514M | 103.29%1.18B | --578M |
| Net common stock issuance | -221.95%-50M | 129.29%41M | ---140M |
| Increase or decrease of lease financing | -20.59%-41M | -9.68%-34M | ---31M |
| Net other fund-raising expenses | ---- | 807.14%99M | ---14M |
| Financing cash flow | -147.23%-605M | 225.95%1.28B | --393M |
| Net cash flow | |||
| Beginning cash position | 68.67%4.4B | 13.44%2.61B | --2.3B |
| Current changes in cash | -36.71%1.12B | 513.89%1.77B | --288M |
| Effect of exchange rate changes | 104.35%47M | 15.00%23M | --20M |
| Cash adjustments other than cash changes | ---- | ---- | --1M |
| End cash Position | 26.51%5.57B | 68.67%4.4B | --2.61B |
| Free cash flow | 59.21%1.89B | 264.72%1.19B | --326M |
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |